Showing results (521-530 of 608) with videos related to

Sort By:
Pageof 61
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 13, 2020
High-dose vitamin D supplementation in multiple sclerosis - results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trialJan Dörr, Priscilla Bäcker-Koduah, Klaus-Dieter Wernecke, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 8, 2019
Patients transitioning from non-pegylated to pegylated interferon beta-1a have a low risk of new flu-like symptoms: ALLOW phase 3b trial resultsRobert T Naismith, Barry Hendin, Sibyl Wray, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 8, 2019
Advanced imaging findings in progressive solitary sclerosis: a single lesion or a global disease?Lisa Eunyoung Lee, Jillian K Chan, Emilie Nevill, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 19, 2018
Updated diagnostic criteria for neuromyelitis optica spectrum disorder: Similar outcomes of previously separate cohortsM McCreary, M A Mealy, D M Wingerchuk, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 4, 2020
PARP-1 deregulation in multiple sclerosisMaria Meira, Claudia Sievers, Francine Hoffmann, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 14, 2020
Prevalence of mental disorders is higher in patients with multiple sclerosis than in the general population or in patients with rheumatoid arthritis in FranceAlice Guilleux, Jonathan Roux, David Travers, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 31, 2019
Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1aErin L MacMillan, Julia J Schubert, Irene M Vavasour, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 31, 2019
HDL-cholesterol elevation associated with fingolimod and dimethyl fumarate therapies in multiple sclerosisS Blumenfeld Kan, E Staun-Ram, D Golan, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 29, 2019
Does a modifiable risk factor score predict disability worsening in people with multiple sclerosis?Claudia H Marck, Zoe Aitken, Steve Simpson, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 23, 2025
A review of the validation of the Brief Cognitive Assessment for Multiple Sclerosis in Latin AmericaMiriam E Jiménez-Maldonado, Edgar R Valdivia-Tangarife, Miguel Ángel Macías-Islas, et al.
Pageof 61